Artificial intelligence takes bioinformatics to the next level
Combining bioinformatics and artificial intelligence is the way forward for many healthcare companies.
BioLizard’s business development director, Liesbeth Ceelen and co-founder, Wim Van Criekinge sit down with Joris Hendrickx from mediaplanet to discuss how bioinformatics and artificial intelligence are increasingly central to the life sciences sector.
Bioinformatics is in its broadest sense is making use of an entire IT arsenal to analyse all possible biological data. With large amounts of data being produced, statistics are not always enough to learn from the data, which is why we need to develop bio-algorithms to harness the most from the data. At BioLizard, we focus on integrating different data (multimodal testing), such as combining an image with additional molecular data.
“Bioinformatics has become the driving force behind the life sciences sector.”
Few biotech, pharmaceutical and diagnostic companies are able to do without bioinformatics analyses today. It has become the driving force behind these sectors and data are now often even the core asset of many companies. However, given the complexity of biological data, it seems difficult for companies to keep bioinformatics skills completely internal. That is precisely why there is a growing need for an expertise company such as BioLizard that develops specialised technologies that can be applied in various companies. In this way, collaborating companies can also enrich each other.
Read more here.
Adapted from Mediaplanet by Kathryn Morrissey for BioLizard.
Related news
We are expanding our services in Switzerland
With the appointment of Per Rigler as Business Development Manager, we expand our business in Switzerland.
Read more
BioLizard Awarded €300,000 VLAIO Research Grant
We are happy to announce the receipt of a research grant from VLAIO to leverage our world-leading expertise in bioinform
Read more